Literature DB >> 3721883

Mucoepidermoid carcinoma of salivary glands: a clinicopathologic study of 46 cases.

A G Nascimento, L P Amaral, L A Prado, J Kligerman, T R Silveira.   

Abstract

Forty-six cases of mucoepidermoid carcinoma (MEC) of the salivary glands were reviewed with an emphasis on the clinicopathologic aspects and prognosis of the tumors. MEC occurred in a wide age range, with few cases being diagnosed in childhood. Its peak of incidence was in the fifth decade and it involved major and minor salivary glands with equal frequency; the parotid gland was the gland most commonly affected. Presence of a mass was the most common complaint of all 46 patients. About 64% of the patients presented with stages 3 and 4 disease. Three distinct histologic grades were found after analyzing cellular pleomorphism, mitotic activity, and presence of necrosis. This study showed that clinical staging and histologic grading are the most important factors influencing survival and they seem to be independent of each other. Other variables found to be important in prognosis were age, sex, and the development of recurrent disease after surgery. Surgery with total resection of the tumor was the most effective treatment in our cases and adjuvant radiotherapy proved to be of little value in improving survival of MEC in our series of cases, considering that the patients in whom this type of treatment was used had unfavorable clinicopathologic factors.

Entities:  

Mesh:

Year:  1986        PMID: 3721883     DOI: 10.1002/hed.2890080604

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  7 in total

1.  Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.

Authors:  Trevor M Feinstein; Stephen Y Lai; Diana Lenzner; William Gooding; Robert L Ferris; Jennifer R Grandis; Eugene N Myers; Jonas T Johnson; Dwight E Heron; Athanassios Argiris
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

2.  [Malignant epithelial salivary gland tumors. Clinical review of 2 decades].

Authors:  H Kokemüller; N Brüggemann; P Brachvogel; A Eckardt
Journal:  Mund Kiefer Gesichtschir       Date:  2004-02-07

3.  Oncocytic mucoepidermoid carcinoma of the parotid gland: case report.

Authors:  Amjad Alshammari; Eman Aljufairi; Anwaar Alsayed
Journal:  J Surg Case Rep       Date:  2022-02-21

Review 4.  Advances in the Treatment of Mucoepidermoid Carcinoma.

Authors:  Srikar Sama; Takefumi Komiya; Achuta Kumar Guddati
Journal:  World J Oncol       Date:  2021-12-08

5.  LINE-1 and Alu hypomethylation in mucoepidermoid carcinoma.

Authors:  Porntipa Sirivanichsuntorn; Somboon Keelawat; Kittipong Danuthai; Apiwat Mutirangura; Keskanya Subbalekha; Nakarin Kitkumthorn
Journal:  BMC Clin Pathol       Date:  2013-03-19

6.  Malignant salivary gland tumours of the head and neck region: a single institutions review.

Authors:  Ahmed Oluwatoyin Lawal; Akinyele Olumuyiwa Adisa; Bamidele Kolude; Bukola Folasade Adeyemi
Journal:  Pan Afr Med J       Date:  2015-02-12

7.  Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma.

Authors:  D Uchida; N-M Begum; A Almofti; H Kawamata; H Yoshida; M Sato
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.